Andrea Pirzkall
Keine laufenden Positionen mehr
Profil
Andrea Pirzkall worked as the Chief Medical Director at Genentech, Inc. from 2007 to 2017.
She then worked as the Executive Director-Clinical Development at BeiGene Ltd.
from 2017 to 2020.
Prior to that, she was the Director-Clinical Affairs at DxTx Medical, Inc. from 2002 to 2003.
Most recently, she served as the Chief Medical Officer at Replimune Group, Inc. from 2020 to 2021.
Pirzkall earned a doctorate degree from Friedrich Schiller University of Jena.
Ehemalige bekannte Positionen von Andrea Pirzkall
Unternehmen | Position | Ende |
---|---|---|
REPLIMUNE GROUP, INC. | Technik-/Wissenschafts-/F&E-Leiter | 25.08.2021 |
BEIGENE, LTD. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2020 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2017 |
DxTx Medical, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 |
Ausbildung von Andrea Pirzkall
Friedrich Schiller University of Jena | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
REPLIMUNE GROUP, INC. | Health Technology |
BEIGENE, LTD. | Health Technology |
Private Unternehmen | 2 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
DxTx Medical, Inc. |